At GAELF3 it was recommended that a Representative Contact Group (RCG) was established composing of country representatives from each of the regions and representatives of a number of other constituencies including pharmaceutical industry, academic/research institutions, donors, non-governmental organisations, the World Health Organization and the World Bank. The RCG elected an Executive Group (EG) of six members with the required skills, commitment and resources to carry out the recommendations made at the GAELF meeting. According to their terms of reference, the mission of the EG is to
"...support GPELF by enhancing the effectiveness of national, regional and global fundraising, advocacy, communication and planning for the Programme."
At GAELF4 the RCG reviewed its own structure electing Dr Mwele Malecela as its Chair, a position which would have a standing position on the EG. Dr Malecela would also be the President of GAELF5 to be held in Tanzania.
GAELF5 was held in April 2008 in Arusha, Tanzania. Extensive discussions on the structure of the EG and the RCG resulted in a larger EG with co-opted country representatives and observers and the RCG setting itself the task of reviewing the terms of office of RCG members.
GAELF6 was held in June 2010 in Seoul, Korea. The theme of the meeting was "Half-time in LF Elimination: Teaming Up with NTDs" highlighted the fact that 2010 marks the midpoint between the first GAELF meeting held in 2000 and the World Health Organization goal of global elimination of LF as a public health problems by 2020. The "half-time" theme provided an appropriate backdrop for reflection, assessment and planning.